Eevia Health Plc receives a 578 KSEK (51 KEUR) sales order for a Bilberry extract product

Eevia Health Plc, (”Eevia” or ”The Company”), has received a 51 KEUR sales order from a European nutraceutical brand owner.

For immediate release

Seinäjoki, Finland 28.06.2025

The customer is a European brand owner headquartered in Sweden. The customer develops and markets effective herbal dietary supplements, as well as cosmetics in over 50.000 pharmacies, health food shops, and other retail outlets across 36 countries, including China and USA.

The sales value to Eevia of this new order is c. 51 KEUR for Feno-Myrtillus® 1, which is a so-called 5:1 bilberry extract, although Eevia’s extract is standardized for anthocyanins. This is a repeat order and one of the few brand holders Eevia services without using a distributor. The business has developed over the last few years, with growing repeat orders. Eevia is selected due to the high quality and authenticity of the product.

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          

Email: stein.ulve@eeviahealth.com  or investor@eeviahealth.com                     

Telephone: +358 400 22 5967                         

INFORMATION ABOUT EEVIA HEALTH PLC

Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name EEVIA.

To learn more, please visit  www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth.